The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 OraSure Technologies Inc.  (OSUR) Trade Now »     Rate OSUR  -  Discuss OSUR  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate OSUR:



OSUR Analysis & Videos »


OSUR: Bull or Bear?

OraSure Announces 2009 Second Quarter Financial Results and Resumption of Full-Scale OraQuick(r) Production Graphic_rating_buy OSUR
Foto
62%
 -0.98%
in 27 days
(closed on 09/02/09)
<font> <font>   Wednesday, August 05, 2009 4:13:29 PM ET </font> </font>

<font> OraSure Technologies, Inc. ( OSUR ), a market leader in oral fluid diagnostics, today announced revenues of $17.3 million for the three months ended June 30, 2009, compared to $18.9 million recorded for the three months ended June 30, 2008. The Company also announced the resolution of the previously disclosed manufacturing issue related to its OraQuick(r) rapid HIV-1/2 antibody test and the resumption of full-scale production of that product. </font>

<> <font> The decrease in revenue for th...
By  Marian Filo   (-24.55%  risk: aggressive)  08/06/09 1 comment


OraSure: Two Diagnostic Tests to Fuel Growth Graphic_rating_buy OSUR
Mikerun
73%
 -10.60%
in 145 days
(closed on 06/25/09)
OraSure: Two Diagnostic Tests to Fuel Growth
 
By Mike Havrilla on 1/31/09
 
<> With shares of CombiMatrix (CBMX) moving up by over 10% since I profiled the company in mid-January as a long-term buy from the ETF Innovators Emerging Diagnostics Index ; a similar opportunity exists today with shares of OraSure Technologies (OSUR). OSUR is a leader in oral fluid diagnostics and also offers cryosurgical systems to remove warts through freezing, which are sold in different forms both ...
By  Mike Havrilla   (+1.04%  risk: moderate)  01/31/09 3 comments


In Search of Healthcare Diamonds in the Rough Graphic_rating_buy OSUR
Mikerun
73%
 -9.87%
in 18 days
(closed on 01/31/09)

In Search of Healthcare Diamonds in the Rough

<> While we are not even halfway through January, the healthcare sector is already active with deal-making, ranging from the rumored $95 buyout of biotech giant Genetech (DNA) by Roche (RHHBY) to Endo's (ENDP) purchase of small-cap, specialty pharma Indevus (IDEV) to Sequenom's (SQNM) $41M offer for emerging diagnostic company EXACT Sciences (EXAS) – which was promptly rebuffed by EXACT's board after the market close on Monday on the promise of a better deal in the works for shareholders.

Larger bio-pharma and diagnost...
By  Mike Havrilla   (+1.04%  risk: moderate)  01/13/09 1 comment


Get free stock alert for OSUR:
Your Email Address:


20 Emerging Healthcare Stocks to Watch in '09 Graphic_rating_buy OSUR
Mikerun
73%
 -3.38%
in 3 days
(closed on 01/13/09)

20 Emerging Healthcare Stocks to Watch in '09

<> As a follow-up to my most recent article on the buyout binge among bio-pharma and diagnostic companies, below is a basket of 20 stocks (listed randomly) to consider from the ETF Innovators Indexes of 250 companies which represent a mix of pending catalysts in the form of clinical trials or FDA decisions, innovative patent portfolios or drug discovery technology platforms, promising compounds in clinical development, and marketed therapeutic or diagnostic products. Click on any of the company names for links to all of my prev...
By  Mike Havrilla   (+1.04%  risk: moderate)  01/10/09 9 comments


Buyout Binge Begins for Bio-Pharma, Diagnostics Graphic_rating_buy OSUR
Mikerun
73%
 +0.00%
in 8 hours
(closed on 01/10/09)

Buyout Binge Begins for Bio-Pharma, Diagnostics

<>
<>
<> With news late Friday that Roche (RHHBY) is prepared to up its bid for complete control of Genentech (DNA) to $95 from a previous offer of $89 per share and a $41M ($1.50 per share) all-stock takeover offer by Sequenom (SQNM) for EXACT Sciences (EXAS); 2009 is off to a strong start for M&A activity in the bio-pharma and diagnostic space.

Larger and well funded bio-pharma and diagnostic companies are opportunistically looking to expand their product offerings, pipeline prospects, patent portfolios, ...
By  Mike Havrilla   (+1.04%  risk: moderate)  01/10/09 1 comment


A New Emerging Diagnostics Index Graphic_rating_buy OSUR
Mikerun
73%
 -9.47%
in 14 days
(closed on 01/10/09)

A New Emerging Diagnostics Index

<>

The accompanying table [click to enlarge] includes 39 companies in the ETF Innovators [ETFI] Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic analysis + molecu...
By  Mike Havrilla   (+1.04%  risk: moderate)  12/26/08 1 comment





People Bullish on OSUR

Foto
Marian Filo
Principal
62%
over 2 years ago

zeitgeber
Analyst
55%
over 3 years ago

starfox863
Analyst
34%
over 4 years ago

John Samuel
Analyst
21%
over 4 years ago

My_pic
Ryan Colby
Analyst
77%
over 5 years ago


People Bearish on OSUR

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.36% 531
2 Gerald Greene 18.14 +36.28% 286
3 stockmarketfunding.com 17.66 +23.07% 83
4 akiralegrand 13.47 +13.37% 69
5 anup2104 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment
RIMM Research in Motion Ltd
RIO Companhia Vale Do Rio Doce
GLD streetTRACKS Gold
POT Potash Corp. of Saskatchewan Inc.
INTC Intel Corp
RIG Transocean Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on OSUR


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About OraSure Technologies Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch